Catalent's financial performance: Revenue, earnings, and profitability directly impact investor confidence and the stock price.

Pharmaceutical industry trends: Growth or decline in the pharmaceutical sector, particularly in areas Catalent serves like biologics and cell/gene therapy, influences demand for its services.

Regulatory environment: Changes in regulations related to drug manufacturing and development can affect Catalent's operations and profitability.

Mergers and acquisitions: Industry consolidation or Catalent's own M&A activity can cause price fluctuations.

Macroeconomic factors: Economic growth, interest rates, and inflation can impact overall market sentiment and investor appetite for risk, affecting the stock.

Competition: The presence and performance of competitors offering similar services can influence Catalent's market share and pricing power.

Investor sentiment: General market optimism or pessimism, news headlines, and analyst ratings can drive short-term price movements.

Company-specific news: Announcements about partnerships, contracts, product launches, or management changes can impact investor perception.

Supply chain disruptions: Issues affecting the availability of raw materials or components needed for Catalent's operations can negatively impact revenue and profitability.